Multicenter Study of Safety and Efficacy of Prolgolimab in Patients With Advanced Melanoma in Routine Clinical Practice
Clinical trial NCT05120024 · UNKNOWN
Trial details
- NCT number
- NCT05120024
- Sponsor
- MelanomaPRO, Russia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-14
- Primary completion
- 2022-12-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.